can you just stop taking glp 1 GLP-1 Medications Without Weight Gain? Why do patients stop GLP-1
Description
Ocular complications from GLP-1 receptor agonists: Clinical evidence, potential mechanisms, and clinical recommendations

Wheeler MB, Lu M, Dillon JS, Leng XH, Chen C, and Boyd AE, 3rd

When the gut ecosystem is disrupted by aging or chronic disease, this metabolite-driven GLP-1 stimulation fails
Wegovy: Conditions treated Qsymia and Wegovy are both approved for chronic weight management in people with obesity who have a body mass index (BMI) of 30 or higher

Prolonged insulin-induced hypoglycaemia reduces ss-cell activity rather than number in pancreatic islets in non-diabetic rats

By addressing multiple health burdens with a single therapy, GLP1s are reshaping how providers think about chronic disease management
